Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017, Article ID 7872519, 9 pages
https://doi.org/10.1155/2017/7872519
Research Article

Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors

1Department of Experimental, Diagnostic and Specialty Medicine, S.Orsola-Malpighi University Hospital, Bologna, Italy
2Department of Diagnostic and Prevention Medicine, S.Orsola-Malpighi University Hospital, Bologna, Italy
3Department of Medical and Surgical Sciences, S.Orsola-Malpighi University Hospital, Bologna, Italy

Correspondence should be addressed to D. Campana; ti.obinu@anapmac.edivad

Received 13 July 2017; Accepted 24 September 2017; Published 29 October 2017

Academic Editor: Piero Chirletti

Copyright © 2017 G. Lamberti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

G. Lamberti, C. Ceccarelli, N. Brighi, et al., “Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors,” Gastroenterology Research and Practice, vol. 2017, Article ID 7872519, 9 pages, 2017. https://doi.org/10.1155/2017/7872519.